MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Treatment Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease: The Search for the Ideal Neuroprotective Drug

    C. Gonzalez-Robles, D. Byrom, R. Chapman, D. Dexter, S. Duty, R. Ellis-Doyle, E. Jabbari, G. Mills, H. Mortiboys, J. Rudiger, E. Sammler, P. Scurfield, S. Stott, G. Tofaris, L. Wei, A. Wong, ML. Zeissler, C. Carroll, T. Foltynie, O. Bandmann, A. Schapira (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatments for…
  • 2022 International Congress

    Head injury prior to Parkinson’s disease predicts faster self-reported motor and cognitive decline

    E. Brown, M. San Luciano, S. Goldman, M. Korell, B. Contreras, C. Tanner (San Francisco, USA)

    Objective: To compare rates of self-reported cognitive and motor decline in people with Parkinson’s Disease (PD) with and without a history of head injury (HI).…
  • 2022 International Congress

    Patient Advisory Boards: A Model for Patient Engagement in Parkinson’s Disease Comparative Effectiveness Research

    K. Schroeder, C. Gallagher, M. Armstrong, M. Carnie, C. Evers, J. Fleisher, B. Kluger, J. Lamb, S. Seshadri, L. Wilson, M. Feeney, P. Davies (New York, USA)

    Objective: To build a replicable, sustainable model of patient engagement in Parkinson’s disease (PD) comparative effectiveness research (CER) at academic research centers through patient advisory…
  • 2022 International Congress

    Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

    C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)

    Objective: We sought to estimate the impact of cardiovascular autonomic neuropathy (cAN) on informal caregivers of patients with Parkinson’s disease (PD), defined as individuals providing regular…
  • 2022 International Congress

    An accurate yet practical method for DBS battery life prediction

    S. Jinks (Sacramento, USA)

    Objective: To develop a simple, accurate algorithm for predicting DBS IPG battery life in patients with PD, ET and dystonia. Background: Battery life for DBS…
  • 2022 International Congress

    Correlation between cognitive impairment and neuropsychiatric symptoms in Mexican persons living with Parkinson’s disease.

    GI. Cerda-Hernández, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

    Objective: To describe the association amongst depression, anxiety, psychosis with cognitive impairment in Mexican people living with Parkinson’s disease (PwP). Background: Cognitive impairment and neuropsychiatric…
  • 2022 International Congress

    PD GENEration Clinical Phase: Genetic Diagnostic Yield and Clinical Characteristics

    L. Cook, J. Verbrugge, T. Schwantes-An, M. Nance, A. Naito, K. Marder, M. Schwarzschild, T. Simuni, A. Wills, A. Hall, J. Schulze, P. Hodges, C. Casaceli, L. Heathers, K. Ghosh, J. Beck, R. Alcalay (Indianapolis, USA)

    Objective: To assess the frequency of reportable variants in major genes associated with Parkinson’s disease (PD) and identify clinical predictors of positive genetic test results.…
  • 2022 International Congress

    Deep learning to distinguish Parkinson’s from controls in video, without human-defined measures

    J. Yang, S. Williams, D. Hogg, J. Alty, S. Relton ()

    Objective: We aimed to apply a deep learning neural network directly to video of finger tapping, without human-defined measures or features, for a computer to…
  • 2022 International Congress

    Characteristics and validity of technologies analyzing voice features to assess symptoms – a review

    J. Dean, V. Iankova Md, S. Schneider (Aurora, USA)

    Objective: Our goal was to review the current literature aiming to (i) list, (ii) compare and (iii) classify voice-based technologies that objectively measure the presence…
  • 2022 International Congress

    Prevalence of Parkinson’s disease and Atypical Parkinsonisms in Colombia: Data from the national health registry 2016-2021

    G. Rincón, J. Torres-García, C. Pantoja-Ruiz, D. Rosselli (Bogotá, Colombia)

    Objective: To estimate prevalence of Parkinson’s Disease (PD) and Atypical Parkinsonisms and characterise the diagnosed population in a country with a development economy Background: The…
  • « Previous Page
  • 1
  • …
  • 342
  • 343
  • 344
  • 345
  • 346
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley